Your search returned 2 results.

Results
	1.	Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma. [electronic resource] by Ouerdani, A Struemper, H Suttle, A B Ouellet, D Ribba, B Producer: 20160119 In: CPT: pharmacometrics & systems pharmacology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings. [electronic resource] by Wilson, S Tod, M Ouerdani, A Emde, A Yarden, Y Adda Berkane, A Kassour, S Wei, M X Freyer, G You, B Grenier, E Ribba, B Producer: 20160223 In: CPT: pharmacometrics & systems pharmacology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search